Skip to main content


Subpage Hero

Stephen Kingsmore

Stephen Kingsmore

Rady Children's Institute for Genomic Medicine
Stephen Kingsmore is President/CEO of Rady Children's Institute for Genomic Medicine which is implementing pediatric genomic medicine across North America. He is also the David F. Hale Chair at Rady Children's Hospital, San Diego. Previously he was the Dee Lyons Chair in Genomic Medicine at the University of Missouri-Kansas City, President of the National Center for Genome Resources, Chief Operating Officer of Molecular Staging Inc., Vice President of Research at CuraGen Corporation, and Assistant Professor at the University of Florida. Dr. Kingsmore received BSc, MB, ChB, BAO and DSc degrees from the Queen's University of Belfast. He did residency in internal medicine and fellowship at Duke University Medical Center. He is a fellow of the Royal College of Pathologists. He was a MedScape Physician of the year in 2012, received the 2013 Scripps Genomic Medicine award, 2013 ILCHUN prize of the Korean Society for Biochemistry and Molecular Biology, and 2022 Precision Medicine World Conference Luminary Award. TIME magazine ranked his rapid genome diagnosis one of the top 10 medical breakthroughs of 2012. RCIGM has held two Guinness World Records for fastest time to genome-based diagnosis of genetic diseases. RCIGM is developing healthcare delivery solutions for rare genetic diseases of children involving artificial intelligence, cloud technology, telemedicine, and digital health. The initial applications are Rapid Precision Medicine – involving rapid genome-based diagnosis in inpatient children – and BeginNGS – involving genome screening of infant populations to detect and treat rare genetic diseases at or before symptom onset.